GALNT9 Antibodies

AND GALNT9 ELISA kits, GALNT9 Proteins

Many biological assays use antibodies to detect GALNT9, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with GALNT9 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop GALNT9 antibodies...

We validate the specificity of these antibodies to GALNT9 by testing them on tissues known to express GALNT9 positively and negatively. Browse below to find the GALNT9 antibody that suites your experiment. We have 1 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: SEPTIN9 Next: IL21R

GALNT9 Infographic by Boster Bio

All GALNT9 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

GALNT9 (NM_021808) Human Over-expression Lysate

Human

$628
Cat # LS050614
100 µg

GALNT9 Overview

Facts about Polypeptide N-acetylgalactosaminyltransferase 9.

GALNT9 3D structure. Source: alphafold

Polypeptide N-acetylgalactosaminyltransferase 9 (GALNT9)

Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Does not glycosylate apomucin or SDC3.

Gene Information

Human
Gene Name:	GALNT9
Uniprot:	Q9HCQ5
Entrez:	50614

Family

Belongs to:

glycosyltransferase 2 family

Alternative Names

EC 2.4.1.41; GalNAc transferase 9; GALNAC-T9; GALNT9 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9); Polypeptide GalNAc transferase 9; polypeptide N-acetylgalactosaminyltransferase 9; pp-GaNTase 9; Protein-UDP acetylgalactosaminyltransferase 9; UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 9; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9; UDP-N-acetyl-alpha-D-galactosamine:polypeptideN-acetylgalactosaminyltransferase 9 (GalNAc-T9)

Molecular Weight

Mass (kDA):
68.359 kDA

Genomic Context


Human

Location:	12q24.33
Sequence:	12; NC_000012.12 (132196372..132329589, complement)

Tissue Specificity

Specifically expressed in brain. Not expressed in heart, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis, ovary, small intestine, colon and leukocyte. In brain, it is expressed in cerebellum, frontal lobe, temporal lobe, putamen and spinal cord, weakly expressed in cerebral cortex. Not expressed in medulla and occipital pole.

Subcellular Localizations

Golgi apparatus membrane; Single-pass type II membrane protein.

Diseases

Neuroblastoma
Anemia
Tumor Progression
Weakness
Mitochondrial Diseases
Mitochondrial Myopathies
Sideroblastic Anemia
Myopathy
Malignant Childhood Neoplasm
Malignant Neoplasms

Obesity
Neoplasms
Mitochondrial Myopathy And Sideroblastic Anemia
Dysequilibrium Syndrome

Pathways

Oxidative Phosphorylation

PTMs

Glycosylation

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/GALNT9

References

PMID: 10978536 by Toba S., et al. Brain-specific expression of a novel human UDP-GalNAc:polypeptide N- acetylgalactosaminyltransferase (GalNAc-T9).

PMID: 12407114 by Zhang Y., et al. Cloning and characterization of a new human UDP-N-acetyl-alpha-D- galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.